Global Gene Therapies for Cancer Treatment Market Size, Status and Forecast 2024-2031

Report ID: 917709 | Published Date: Sep 2024 | No. of Page: 107 | Base Year: 2023 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Somatic Cell Gene Therapy (SCGT)
        1.2.3 Germline Gene Therapy (GGT)
    1.3 Market by Application
        1.3.1 Global Gene Therapies for Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Cancer Research Centers
        1.3.3 Diagnostic Laboratories
        1.3.4 Cancer Hospitals
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Gene Therapies for Cancer Treatment Market Perspective (2016-2027)
    2.2 Gene Therapies for Cancer Treatment Growth Trends by Regions
        2.2.1 Gene Therapies for Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Gene Therapies for Cancer Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Gene Therapies for Cancer Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Gene Therapies for Cancer Treatment Industry Dynamic
        2.3.1 Gene Therapies for Cancer Treatment Market Trends
        2.3.2 Gene Therapies for Cancer Treatment Market Drivers
        2.3.3 Gene Therapies for Cancer Treatment Market Challenges
        2.3.4 Gene Therapies for Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Gene Therapies for Cancer Treatment Players by Revenue
        3.1.1 Global Top Gene Therapies for Cancer Treatment Players by Revenue (2016-2021)
        3.1.2 Global Gene Therapies for Cancer Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Gene Therapies for Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Gene Therapies for Cancer Treatment Revenue
    3.4 Global Gene Therapies for Cancer Treatment Market Concentration Ratio
        3.4.1 Global Gene Therapies for Cancer Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gene Therapies for Cancer Treatment Revenue in 2020
    3.5 Gene Therapies for Cancer Treatment Key Players Head office and Area Served
    3.6 Key Players Gene Therapies for Cancer Treatment Product Solution and Service
    3.7 Date of Enter into Gene Therapies for Cancer Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapies for Cancer Treatment Breakdown Data by Type
    4.1 Global Gene Therapies for Cancer Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Gene Therapies for Cancer Treatment Breakdown Data by Application
    5.1 Global Gene Therapies for Cancer Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Gene Therapies for Cancer Treatment Market Size (2016-2027)
    6.2 North America Gene Therapies for Cancer Treatment Market Size by Type
        6.2.1 North America Gene Therapies for Cancer Treatment Market Size by Type (2016-2021)
        6.2.2 North America Gene Therapies for Cancer Treatment Market Size by Type (2022-2027)
        6.2.3 North America Gene Therapies for Cancer Treatment Market Size by Type (2016-2027)
    6.3 North America Gene Therapies for Cancer Treatment Market Size by Application
        6.3.1 North America Gene Therapies for Cancer Treatment Market Size by Application (2016-2021)
        6.3.2 North America Gene Therapies for Cancer Treatment Market Size by Application (2022-2027)
        6.3.3 North America Gene Therapies for Cancer Treatment Market Size by Application (2016-2027)
    6.4 North America Gene Therapies for Cancer Treatment Market Size by Country
        6.4.1 North America Gene Therapies for Cancer Treatment Market Size by Country (2016-2021)
        6.4.2 North America Gene Therapies for Cancer Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Gene Therapies for Cancer Treatment Market Size (2016-2027)
    7.2 Europe Gene Therapies for Cancer Treatment Market Size by Type
        7.2.1 Europe Gene Therapies for Cancer Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Gene Therapies for Cancer Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Gene Therapies for Cancer Treatment Market Size by Type (2016-2027)
    7.3 Europe Gene Therapies for Cancer Treatment Market Size by Application
        7.3.1 Europe Gene Therapies for Cancer Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Gene Therapies for Cancer Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Gene Therapies for Cancer Treatment Market Size by Application (2016-2027)
    7.4 Europe Gene Therapies for Cancer Treatment Market Size by Country
        7.4.1 Europe Gene Therapies for Cancer Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Gene Therapies for Cancer Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Gene Therapies for Cancer Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Type
        8.2.1 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Application
        8.3.1 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region
        8.4.1 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Gene Therapies for Cancer Treatment Market Size (2016-2027)
    9.2 Latin America Gene Therapies for Cancer Treatment Market Size by Type
        9.2.1 Latin America Gene Therapies for Cancer Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Gene Therapies for Cancer Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Gene Therapies for Cancer Treatment Market Size by Type (2016-2027)
    9.3 Latin America Gene Therapies for Cancer Treatment Market Size by Application
        9.3.1 Latin America Gene Therapies for Cancer Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Gene Therapies for Cancer Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Gene Therapies for Cancer Treatment Market Size by Application (2016-2027)
    9.4 Latin America Gene Therapies for Cancer Treatment Market Size by Country
        9.4.1 Latin America Gene Therapies for Cancer Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Gene Therapies for Cancer Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Gene Therapies for Cancer Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Type
        10.2.1 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Application
        10.3.1 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country
        10.4.1 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Takara Bio
        11.1.1 Takara Bio Company Details
        11.1.2 Takara Bio Business Overview
        11.1.3 Takara Bio Gene Therapies for Cancer Treatment Introduction
        11.1.4 Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.1.5 Takara Bio Recent Development
    11.2 Tocagen
        11.2.1 Tocagen Company Details
        11.2.2 Tocagen Business Overview
        11.2.3 Tocagen Gene Therapies for Cancer Treatment Introduction
        11.2.4 Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.2.5 Tocagen Recent Development
    11.3 VBL Therapeutics
        11.3.1 VBL Therapeutics Company Details
        11.3.2 VBL Therapeutics Business Overview
        11.3.3 VBL Therapeutics Gene Therapies for Cancer Treatment Introduction
        11.3.4 VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.3.5 VBL Therapeutics Recent Development
    11.4 Cold Genesys
        11.4.1 Cold Genesys Company Details
        11.4.2 Cold Genesys Business Overview
        11.4.3 Cold Genesys Gene Therapies for Cancer Treatment Introduction
        11.4.4 Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.4.5 Cold Genesys Recent Development
    11.5 Genprex
        11.5.1 Genprex Company Details
        11.5.2 Genprex Business Overview
        11.5.3 Genprex Gene Therapies for Cancer Treatment Introduction
        11.5.4 Genprex Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.5.5 Genprex Recent Development
    11.6 Momotaro-Gene
        11.6.1 Momotaro-Gene Company Details
        11.6.2 Momotaro-Gene Business Overview
        11.6.3 Momotaro-Gene Gene Therapies for Cancer Treatment Introduction
        11.6.4 Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.6.5 Momotaro-Gene Recent Development
    11.7 MultiVir
        11.7.1 MultiVir Company Details
        11.7.2 MultiVir Business Overview
        11.7.3 MultiVir Gene Therapies for Cancer Treatment Introduction
        11.7.4 MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.7.5 MultiVir Recent Development
    11.8 SynerGene Therapeutics
        11.8.1 SynerGene Therapeutics Company Details
        11.8.2 SynerGene Therapeutics Business Overview
        11.8.3 SynerGene Therapeutics Gene Therapies for Cancer Treatment Introduction
        11.8.4 SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.8.5 SynerGene Therapeutics Recent Development
    11.9 Ziopharm Oncology
        11.9.1 Ziopharm Oncology Company Details
        11.9.2 Ziopharm Oncology Business Overview
        11.9.3 Ziopharm Oncology Gene Therapies for Cancer Treatment Introduction
        11.9.4 Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.9.5 Ziopharm Oncology Recent Development
    11.10 Anchiano Therapeutics
        11.10.1 Anchiano Therapeutics Company Details
        11.10.2 Anchiano Therapeutics Business Overview
        11.10.3 Anchiano Therapeutics Gene Therapies for Cancer Treatment Introduction
        11.10.4 Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.10.5 Anchiano Therapeutics Recent Development
    11.11 Celgene
        11.11.1 Celgene Company Details
        11.11.2 Celgene Business Overview
        11.11.3 Celgene Gene Therapies for Cancer Treatment Introduction
        11.11.4 Celgene Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.11.5 Celgene Recent Development
    11.12 Celsion
        11.12.1 Celsion Company Details
        11.12.2 Celsion Business Overview
        11.12.3 Celsion Gene Therapies for Cancer Treatment Introduction
        11.12.4 Celsion Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.12.5 Celsion Recent Development
    11.13 Bluebird Bio
        11.13.1 Bluebird Bio Company Details
        11.13.2 Bluebird Bio Business Overview
        11.13.3 Bluebird Bio Gene Therapies for Cancer Treatment Introduction
        11.13.4 Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.13.5 Bluebird Bio Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Somatic Cell Gene Therapy (SCGT)
    Table 3. Key Players of Germline Gene Therapy (GGT)
    Table 4. Global Gene Therapies for Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Gene Therapies for Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Gene Therapies for Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Gene Therapies for Cancer Treatment Market Share by Regions (2016-2021)
    Table 8. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Gene Therapies for Cancer Treatment Market Share by Regions (2022-2027)
    Table 10. Gene Therapies for Cancer Treatment Market Trends
    Table 11. Gene Therapies for Cancer Treatment Market Drivers
    Table 12. Gene Therapies for Cancer Treatment Market Challenges
    Table 13. Gene Therapies for Cancer Treatment Market Restraints
    Table 14. Global Gene Therapies for Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Gene Therapies for Cancer Treatment Market Share by Players (2016-2021)
    Table 16. Global Top Gene Therapies for Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapies for Cancer Treatment as of 2020)
    Table 17. Ranking of Global Top Gene Therapies for Cancer Treatment Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Gene Therapies for Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Gene Therapies for Cancer Treatment Product Solution and Service
    Table 21. Date of Enter into Gene Therapies for Cancer Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Gene Therapies for Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2016-2021)
    Table 25. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Gene Therapies for Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Gene Therapies for Cancer Treatment Revenue Market Share by Application (2016-2021)
    Table 29. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Gene Therapies for Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Gene Therapies for Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Gene Therapies for Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Gene Therapies for Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Gene Therapies for Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Gene Therapies for Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Gene Therapies for Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Gene Therapies for Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Gene Therapies for Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Gene Therapies for Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Gene Therapies for Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Gene Therapies for Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Gene Therapies for Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Gene Therapies for Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Gene Therapies for Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Gene Therapies for Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Gene Therapies for Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Gene Therapies for Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Gene Therapies for Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Takara Bio Company Details
    Table 62. Takara Bio Business Overview
    Table 63. Takara Bio Gene Therapies for Cancer Treatment Product
    Table 64. Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 65. Takara Bio Recent Development
    Table 66. Tocagen Company Details
    Table 67. Tocagen Business Overview
    Table 68. Tocagen Gene Therapies for Cancer Treatment Product
    Table 69. Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 70. Tocagen Recent Development
    Table 71. VBL Therapeutics Company Details
    Table 72. VBL Therapeutics Business Overview
    Table 73. VBL Therapeutics Gene Therapies for Cancer Treatment Product
    Table 74. VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 75. VBL Therapeutics Recent Development
    Table 76. Cold Genesys Company Details
    Table 77. Cold Genesys Business Overview
    Table 78. Cold Genesys Gene Therapies for Cancer Treatment Product
    Table 79. Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 80. Cold Genesys Recent Development
    Table 81. Genprex Company Details
    Table 82. Genprex Business Overview
    Table 83. Genprex Gene Therapies for Cancer Treatment Product
    Table 84. Genprex Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 85. Genprex Recent Development
    Table 86. Momotaro-Gene Company Details
    Table 87. Momotaro-Gene Business Overview
    Table 88. Momotaro-Gene Gene Therapies for Cancer Treatment Product
    Table 89. Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 90. Momotaro-Gene Recent Development
    Table 91. MultiVir Company Details
    Table 92. MultiVir Business Overview
    Table 93. MultiVir Gene Therapies for Cancer Treatment Product
    Table 94. MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 95. MultiVir Recent Development
    Table 96. SynerGene Therapeutics Company Details
    Table 97. SynerGene Therapeutics Business Overview
    Table 98. SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 99. SynerGene Therapeutics Recent Development
    Table 100. Ziopharm Oncology Company Details
    Table 101. Ziopharm Oncology Business Overview
    Table 102. Ziopharm Oncology Gene Therapies for Cancer Treatment Product
    Table 103. Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 104. Ziopharm Oncology Recent Development
    Table 105. Anchiano Therapeutics Company Details
    Table 106. Anchiano Therapeutics Business Overview
    Table 107. Anchiano Therapeutics Gene Therapies for Cancer Treatment Product
    Table 108. Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 109. Anchiano Therapeutics Recent Development
    Table 110. Celgene Company Details
    Table 111. Celgene Business Overview
    Table 112. Celgene Gene Therapies for Cancer Treatment Product
    Table 113. Celgene Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 114. Celgene Recent Development
    Table 115. Celsion Company Details
    Table 116. Celsion Business Overview
    Table 117. Celsion Gene Therapies for Cancer Treatment Product
    Table 118. Celsion Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 119. Celsion Recent Development
    Table 120. Bluebird Bio Company Details
    Table 121. Bluebird Bio Business Overview
    Table 122. Bluebird Bio Gene Therapies for Cancer Treatment Product
    Table 123. Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 124. Bluebird Bio Recent Development
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gene Therapies for Cancer Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Somatic Cell Gene Therapy (SCGT) Features
    Figure 3. Germline Gene Therapy (GGT) Features
    Figure 4. Global Gene Therapies for Cancer Treatment Market Share by Application: 2020 VS 2027
    Figure 5. Cancer Research Centers Case Studies
    Figure 6. Diagnostic Laboratories Case Studies
    Figure 7. Cancer Hospitals Case Studies
    Figure 8. Others Case Studies
    Figure 9. Gene Therapies for Cancer Treatment Report Years Considered
    Figure 10. Global Gene Therapies for Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Gene Therapies for Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Gene Therapies for Cancer Treatment Market Share by Regions: 2020 VS 2027
    Figure 13. Global Gene Therapies for Cancer Treatment Market Share by Regions (2022-2027)
    Figure 14. Global Gene Therapies for Cancer Treatment Market Share by Players in 2020
    Figure 15. Global Top Gene Therapies for Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapies for Cancer Treatment as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Gene Therapies for Cancer Treatment Revenue in 2020
    Figure 17. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2016-2021)
    Figure 18. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2022-2027)
    Figure 19. North America Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Gene Therapies for Cancer Treatment Market Share by Type (2016-2027)
    Figure 21. North America Gene Therapies for Cancer Treatment Market Share by Application (2016-2027)
    Figure 22. North America Gene Therapies for Cancer Treatment Market Share by Country (2016-2027)
    Figure 23. United States Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Gene Therapies for Cancer Treatment Market Share by Type (2016-2027)
    Figure 27. Europe Gene Therapies for Cancer Treatment Market Share by Application (2016-2027)
    Figure 28. Europe Gene Therapies for Cancer Treatment Market Share by Country (2016-2027)
    Figure 29. Germany Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Gene Therapies for Cancer Treatment Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Gene Therapies for Cancer Treatment Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Gene Therapies for Cancer Treatment Market Share by Region (2016-2027)
    Figure 39. China Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Gene Therapies for Cancer Treatment Market Share by Type (2016-2027)
    Figure 47. Latin America Gene Therapies for Cancer Treatment Market Share by Application (2016-2027)
    Figure 48. Latin America Gene Therapies for Cancer Treatment Market Share by Country (2016-2027)
    Figure 49. Mexico Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Gene Therapies for Cancer Treatment Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Gene Therapies for Cancer Treatment Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Gene Therapies for Cancer Treatment Market Share by Country (2016-2027)
    Figure 55. Turkey Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Takara Bio Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021)
    Figure 59. Tocagen Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021)
    Figure 60. VBL Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021)
    Figure 61. Cold Genesys Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021)
    Figure 62. Genprex Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021)
    Figure 63. Momotaro-Gene Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021)
    Figure 64. MultiVir Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021)
    Figure 65. SynerGene Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021)
    Figure 66. Ziopharm Oncology Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021)
    Figure 67. Anchiano Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021)
    Figure 68. Celgene Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021)
    Figure 69. Celsion Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021)
    Figure 70. Bluebird Bio Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Takara Bio
Tocagen
VBL Therapeutics
Cold Genesys
Genprex
Momotaro-Gene
MultiVir
SynerGene Therapeutics
Ziopharm Oncology
Anchiano Therapeutics
Celgene
Celsion
Bluebird Bio
Frequently Asked Questions
Gene Therapies for Cancer Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gene Therapies for Cancer Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gene Therapies for Cancer Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports